Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA

米诺环素 药效学 利福平 医学 药代动力学 药理学 抗生素 人口 皮肤感染 群体药代动力学 金黄色葡萄球菌 微生物学 肺结核 生物 病理 环境卫生 遗传学 细菌
作者
Sònia Luque,William Hope,Antigone Kotsaki,Shampa Das,Evangelos J. Giamarellos‐Bourboulis,Theano Kontopoulouk,Karolina Akinosoglou,Miriam O’Hare,Marie Attwood,Karen E. Bowker,Alan Noel,Andrew Lovering,Mark Bayliss,Rebecca Evans,Alasdair MacGowan
出处
期刊:Journal of Antimicrobial Chemotherapy [Oxford University Press]
卷期号:79 (12): 3303-3312 被引量:2
标识
DOI:10.1093/jac/dkae363
摘要

Abstract Background The population pharmacokinetics/pharmacodynamics (PK/PD) of minocycline, rifampicin and linezolid in patients with complicated skin and soft tissue infections (cSSTIs) caused by MRSA are described. Methods Samples were collected in a Phase 4 study of oral minocycline plus rifampicin versus linezolid showing minocycline plus rifampicin to be non-inferior to linezolid. Antibiotics were assayed by HPLC or LC-MS, and a population PK model was developed using Pmetrics. The association between PK/PD indices and patient outcomes was explored. Results A three-compartment model (with an absorption compartment) with first-order input and elimination best described the data for the three drugs. No covariates were included in the final model. The population median values (95% credibility limits) of the clearance and volume of distribution were 7.412 L/h (5.121–8.361) and 14.155 L (6.799–33.901) for minocycline, 5.683 L/h (3.703–7.726) and 7.736 L (6.031–8.948) for rifampicin, and 1.970 L/h (1.326–2.499) and 20.169 L (12.857–32.629) for linezolid, respectively. Maximum a posteriori probability-Bayesian estimation plots of observed versus predicted had a slope of 0.999 r20.967 for minocycline, slope 0.998 r20.769 for rifampicin and slope 0.998 r20.895 for linezolid. PK/PD indices were not related to clinical outcome. Taking a translational minocycline fAUC24h/MIC target of >0.5 for minocycline in the presence of rifampicin, 96% (49/51) of patients reached the target. Conclusions Population PK models of minocycline, rifampicin and linezolid were developed in patients with MRSA cSSTI and almost all patients reached the predefined PD index targets. As a result, neither AUC, MIC nor the AUC/MIC ratio could be related to clinical outcome.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
nan完成签到,获得积分10
1秒前
大佬完成签到,获得积分10
2秒前
2秒前
3秒前
3秒前
共享精神的应助被云隐采纳,获得10
4秒前
^O^完成签到,获得积分10
4秒前
Aegleseeker完成签到,获得积分10
5秒前
咻咻完成签到,获得积分10
6秒前
我我我发布了新的文献求助10
6秒前
依然完成签到,获得积分10
7秒前
7秒前
qzh006完成签到,获得积分10
7秒前
7秒前
小蘑菇的应助被geat采纳,获得10
7秒前
淡然雅寒完成签到 ,获得积分10
8秒前
8秒前
烟花的应助被暴龙战士采纳,获得10
8秒前
春桑早点睡完成签到,获得积分10
9秒前
桐桐的应助被墨洋采纳,获得10
9秒前
9秒前
MMLi发布了新的文献求助10
9秒前
俊逸的又琴完成签到 ,获得积分10
9秒前
CipherSage的应助被赫江涛采纳,获得10
10秒前
jessie完成签到,获得积分20
10秒前
10秒前
兴奋的凤发布了新的文献求助20
10秒前
10秒前
聪慧含芙发布了新的文献求助10
11秒前
冷艳小蚂蚁完成签到,获得积分10
11秒前
11秒前
爆米花的应助被saturnring采纳,获得10
12秒前
大模型的应助被仙女不喝酒采纳,获得10
12秒前
春衫完成签到,获得积分10
13秒前
染染完成签到 ,获得积分10
13秒前
15秒前
16秒前
仰望星空完成签到,获得积分10
17秒前
18秒前
别构调节关注了科研通微信公众号
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193514
求助须知:如何正确求助?哪些是违规求助? 9579686
关于积分的说明 21866883
捐赠科研通 7793152
什么是DOI,文献DOI怎么找? 3437297
关于科研通互助平台的介绍 2560725
邀请新用户注册赠送积分活动 2484176